Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Luxembourg
Office for Official Publ. of the Europ. Communities
1999
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 114 S. graph. Darst. |
| ISBN: | 9291680877 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV012866192 | ||
| 003 | DE-604 | ||
| 005 | 20020827 | ||
| 007 | t| | ||
| 008 | 991118s1999 be d||| |||| 10||| eng d | ||
| 020 | |a 9291680877 |9 92-9168-087-7 | ||
| 035 | |a (OCoLC)231824284 | ||
| 035 | |a (DE-599)BVBBV012866192 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 044 | |a be |c XA-BE | ||
| 049 | |a DE-12 |a DE-355 |a DE-20 |a DE-521 | ||
| 050 | 0 | |a RC568.A45R47 1999 | |
| 082 | 0 | |a 362.29/9 21 | |
| 084 | |a MS 6410 |0 (DE-625)123754: |2 rvk | ||
| 084 | |a PS 3884 |0 (DE-625)139813: |2 rvk | ||
| 245 | 1 | 0 | |a Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs |c EMCDDA, European Monitoring Centre for Drugs and Drug Addiction |
| 264 | 1 | |a Luxembourg |b Office for Official Publ. of the Europ. Communities |c 1999 | |
| 300 | |a 114 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 610 | 2 | 7 | |a Europäische Union |0 (DE-588)5098525-5 |2 gnd |9 rswk-swf |
| 650 | 7 | |a Droghe - consumo - Europa |2 sbt | |
| 650 | 7 | |a Droghe - consumo - aspetti giuridici - Europa |2 sbt | |
| 650 | 7 | |a Ecstasy - consumo - Europa |2 sbt | |
| 650 | 7 | |a Tossicomania - prevenzione - Europa |2 sbt | |
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Amphetamine abuse -- European Union countries | |
| 650 | 4 | |a Amphetamines -- Derivatives -- Side effects | |
| 650 | 4 | |a Drug monitoring -- Government policy -- European Union countries | |
| 650 | 0 | 7 | |a Gesundheitsgefährdung |0 (DE-588)4071808-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Drogenmissbrauch |0 (DE-588)4070587-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Methylthioamphetamin |g 4- |0 (DE-588)4574257-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Drogenpolitik |0 (DE-588)4140775-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 651 | 4 | |a Europäische Union. Mitgliedsstaaten | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Methylthioamphetamin |g 4- |0 (DE-588)4574257-1 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Europäische Union |0 (DE-588)5098525-5 |D b |
| 689 | 1 | 1 | |a Methylthioamphetamin |g 4- |0 (DE-588)4574257-1 |D s |
| 689 | 1 | 2 | |a Drogenpolitik |0 (DE-588)4140775-1 |D s |
| 689 | 1 | |8 1\p |5 DE-604 | |
| 689 | 2 | 0 | |a Drogenmissbrauch |0 (DE-588)4070587-0 |D s |
| 689 | 2 | 1 | |a Methylthioamphetamin |g 4- |0 (DE-588)4574257-1 |D s |
| 689 | 2 | 2 | |a Gesundheitsgefährdung |0 (DE-588)4071808-6 |D s |
| 689 | 2 | |8 2\p |5 DE-604 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008755722&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-008755722 | |
Datensatz im Suchindex
| _version_ | 1820128017292197888 |
|---|---|
| adam_text |
E.M.C.D.D.A. EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION
REPORT ON THE RISK ASSESSMENT OF 4-MTA IN THE FRAMEWORK OF THE JOINT
ACTION ON NEW SYNTHETIC DRUGS CONTENTS FOREWORD 5 ABBREVIATIONS 7 7
INTRODUCTION 9 REPORT ON THE RISK ASSESSMENT OF 4-MTA IN THE FRAMEWORK
OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS 11 COUNCIL DECISION OF 13
SEPTEMBER 1999 DEFINING 4-MTA AS A NEW SYNTHETIC DRUG WHICH IS TO BE
MADE SUBJECT TO CONTROL MEASURES AND CRIMINAL PENALTIES 21
EUROPOL-EMCDDA PROGRESS REPORT ON 4-MTA IN ACCORDANCE WITH ARTICLE 3 OF
THE JOINT ACTION OF 16 JUNE 1997 CONCERNING THE INFORMATION EXCHANGE,
RISK ASSESSMENT AND THE CONTROL OF NEW SYNTHETIC DRUGS 23 REVIEW OF THE
PHARMACOTOXICOLOGICAL DATA ON 4-MTA 29 PUBLIC HEALTH RISKS OF 4-MTA:
EPIDEMIOLOGICAL EVIDENCE 75 SOCIOLOGICAL AND CRIMINOLOGICAL EVIDENCE ON
THE RISKS OF 4-MTA 85 REFERENCES 101 PARTICIPANTS IN THE RISK-ASSESSMENT
PROCESS 111 |
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV012866192 |
| callnumber-first | R - Medicine |
| callnumber-label | RC568 |
| callnumber-raw | RC568.A45R47 1999 |
| callnumber-search | RC568.A45R47 1999 |
| callnumber-sort | RC 3568 A45 R47 41999 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | MS 6410 PS 3884 |
| ctrlnum | (OCoLC)231824284 (DE-599)BVBBV012866192 |
| dewey-full | 362.29/921 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.29/9 21 |
| dewey-search | 362.29/9 21 |
| dewey-sort | 3362.29 19 221 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Rechtswissenschaft Soziologie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV012866192</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20020827</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">991118s1999 be d||| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9291680877</subfield><subfield code="9">92-9168-087-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231824284</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012866192</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">be</subfield><subfield code="c">XA-BE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-521</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC568.A45R47 1999</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.29/9 21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MS 6410</subfield><subfield code="0">(DE-625)123754:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PS 3884</subfield><subfield code="0">(DE-625)139813:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs</subfield><subfield code="c">EMCDDA, European Monitoring Centre for Drugs and Drug Addiction</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Luxembourg</subfield><subfield code="b">Office for Official Publ. of the Europ. Communities</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">114 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Droghe - consumo - Europa</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Droghe - consumo - aspetti giuridici - Europa</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ecstasy - consumo - Europa</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tossicomania - prevenzione - Europa</subfield><subfield code="2">sbt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphetamine abuse -- European Union countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphetamines -- Derivatives -- Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug monitoring -- Government policy -- European Union countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsgefährdung</subfield><subfield code="0">(DE-588)4071808-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogenmissbrauch</subfield><subfield code="0">(DE-588)4070587-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Methylthioamphetamin</subfield><subfield code="g">4-</subfield><subfield code="0">(DE-588)4574257-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogenpolitik</subfield><subfield code="0">(DE-588)4140775-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Europäische Union. Mitgliedsstaaten</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Methylthioamphetamin</subfield><subfield code="g">4-</subfield><subfield code="0">(DE-588)4574257-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Methylthioamphetamin</subfield><subfield code="g">4-</subfield><subfield code="0">(DE-588)4574257-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Drogenpolitik</subfield><subfield code="0">(DE-588)4140775-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Drogenmissbrauch</subfield><subfield code="0">(DE-588)4070587-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Methylthioamphetamin</subfield><subfield code="g">4-</subfield><subfield code="0">(DE-588)4574257-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Gesundheitsgefährdung</subfield><subfield code="0">(DE-588)4071808-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008755722&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008755722</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | Europäische Union. Mitgliedsstaaten |
| geographic_facet | Europäische Union. Mitgliedsstaaten |
| id | DE-604.BV012866192 |
| illustrated | Illustrated |
| indexdate | 2025-01-02T09:15:42Z |
| institution | BVB |
| isbn | 9291680877 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008755722 |
| oclc_num | 231824284 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-20 DE-521 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-20 DE-521 |
| physical | 114 S. graph. Darst. |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Office for Official Publ. of the Europ. Communities |
| record_format | marc |
| spelling | Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs EMCDDA, European Monitoring Centre for Drugs and Drug Addiction Luxembourg Office for Official Publ. of the Europ. Communities 1999 114 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Europäische Union (DE-588)5098525-5 gnd rswk-swf Droghe - consumo - Europa sbt Droghe - consumo - aspetti giuridici - Europa sbt Ecstasy - consumo - Europa sbt Tossicomania - prevenzione - Europa sbt Politik Amphetamine abuse -- European Union countries Amphetamines -- Derivatives -- Side effects Drug monitoring -- Government policy -- European Union countries Gesundheitsgefährdung (DE-588)4071808-6 gnd rswk-swf Drogenmissbrauch (DE-588)4070587-0 gnd rswk-swf Methylthioamphetamin 4- (DE-588)4574257-1 gnd rswk-swf Drogenpolitik (DE-588)4140775-1 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Europäische Union. Mitgliedsstaaten (DE-588)1071861417 Konferenzschrift gnd-content Methylthioamphetamin 4- (DE-588)4574257-1 s Pharmakologie (DE-588)4045687-0 s DE-604 Europäische Union (DE-588)5098525-5 b Drogenpolitik (DE-588)4140775-1 s 1\p DE-604 Drogenmissbrauch (DE-588)4070587-0 s Gesundheitsgefährdung (DE-588)4071808-6 s 2\p DE-604 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008755722&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs Europäische Union (DE-588)5098525-5 gnd Droghe - consumo - Europa sbt Droghe - consumo - aspetti giuridici - Europa sbt Ecstasy - consumo - Europa sbt Tossicomania - prevenzione - Europa sbt Politik Amphetamine abuse -- European Union countries Amphetamines -- Derivatives -- Side effects Drug monitoring -- Government policy -- European Union countries Gesundheitsgefährdung (DE-588)4071808-6 gnd Drogenmissbrauch (DE-588)4070587-0 gnd Methylthioamphetamin 4- (DE-588)4574257-1 gnd Drogenpolitik (DE-588)4140775-1 gnd Pharmakologie (DE-588)4045687-0 gnd |
| subject_GND | (DE-588)5098525-5 (DE-588)4071808-6 (DE-588)4070587-0 (DE-588)4574257-1 (DE-588)4140775-1 (DE-588)4045687-0 (DE-588)1071861417 |
| title | Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs |
| title_auth | Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs |
| title_exact_search | Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs |
| title_full | Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs EMCDDA, European Monitoring Centre for Drugs and Drug Addiction |
| title_fullStr | Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs EMCDDA, European Monitoring Centre for Drugs and Drug Addiction |
| title_full_unstemmed | Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs EMCDDA, European Monitoring Centre for Drugs and Drug Addiction |
| title_short | Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs |
| title_sort | report on the risk assessment of 4 mta in the framework of the joint action on new synthetic drugs |
| topic | Europäische Union (DE-588)5098525-5 gnd Droghe - consumo - Europa sbt Droghe - consumo - aspetti giuridici - Europa sbt Ecstasy - consumo - Europa sbt Tossicomania - prevenzione - Europa sbt Politik Amphetamine abuse -- European Union countries Amphetamines -- Derivatives -- Side effects Drug monitoring -- Government policy -- European Union countries Gesundheitsgefährdung (DE-588)4071808-6 gnd Drogenmissbrauch (DE-588)4070587-0 gnd Methylthioamphetamin 4- (DE-588)4574257-1 gnd Drogenpolitik (DE-588)4140775-1 gnd Pharmakologie (DE-588)4045687-0 gnd |
| topic_facet | Europäische Union Droghe - consumo - Europa Droghe - consumo - aspetti giuridici - Europa Ecstasy - consumo - Europa Tossicomania - prevenzione - Europa Politik Amphetamine abuse -- European Union countries Amphetamines -- Derivatives -- Side effects Drug monitoring -- Government policy -- European Union countries Gesundheitsgefährdung Drogenmissbrauch Methylthioamphetamin 4- Drogenpolitik Pharmakologie Europäische Union. Mitgliedsstaaten Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008755722&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |